Nalaganje...
Pancreatic adenocarcinoma: Beyond first line, where are we?
Pancreatic cancer is considered one of the most aggressive cancers, with an increasing incidence in recent years. To date, chemotherapy is still the standard of care for advanced metastatic disease, unfortunately providing only a slight advantage in terms of survival. The molecular and cellular char...
Shranjeno v:
| izdano v: | World J Gastroenterol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8108033/ https://ncbi.nlm.nih.gov/pubmed/34007126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i17.1847 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|